Medication Safety Intensive (MSI) workshop is organized by Institute for Safe Medication Practices (ISMP) and will be held from Dec 06 - 07, 2019 at Maggiano's Little Italy, Las Vegas, Nevada, United States of America.
Practitioners in acute care with responsibility for medication safety oversight including:
• Medication Safety and Patient Safety Officers/Managers
• Risk and Quality Improvement Professionals
• Directors of Pharmacy and Nursing
• Clinical Leads/Nurse Managers
• Chief Medical Officers
• Frontline clinical staff interested in medication safety
• Pharmacy Residents
This program is approved for up to 12.5 hours (1.25 CEUs) of continuing pharmacy education.
This program has been assigned the Universal Program Number CEP 13677 and is approved for 12.5 contact hours (1.25 CEUs) of continuing nursing education.
Three-times-a-year for more than a decade, practitioners from around country and outside of the U.S. gather to attend the highly-praised Medication Safety Intensive (MSI) workshop. This unique two-day program led by ISMP faculty and other selected medication safety experts is designed to help you substantially enhance your effectiveness in meeting today’s medication safety challenges.
Whether you are a pharmacist or nurse leader, a physician or dedicated safety officer, from an inpatient facility, or an outpatient setting, our faculty will challenge you to look at your organization through the eyes of the world’s leading safety experts and regulatory agencies, focusing efforts on medication-related issues that impact patient safety. You will engage in group discussions, participate in hands-on practice in error analysis and behavior identification, evaluate latent and active failures related to medication errors, learn how to effectively select high-leverage strategies, and use data to help sustain safety efforts within your organization.
Upon completion of the workshop, you will be armed with the specific knowledge and tools needed to be successful in establishing an aggressive, yet focused medication safety program and the associated infrastructure for continued safety improvements.
Following completion of this workshop, participants will be able to:
• Perform system-based medication error analysis.
• Identify latent and active failures that lead to medication error events.
• Develop error-reduction strategies for the use of high-alert medications.
• Utilize various data collection methods to identify medication-related risk.
• Discuss the role and responsibilities of the medication safety officer or individual(s) responsible for medication safety oversight.
• Identify tools available to advance medication safety initiatives.
• Identify human error, at-risk behavior, and reckless behaviors from case studies.
• Describe appropriate organizational responses to human error and behavioral choices.
• Measure the effectiveness of selected error-reduction strategies.
• Network with other practitioners to problem solve challenging medication safety issues.
Additional details will be posted as soon as they are available.
|Contact No. :||215-947-7797
|Registration Type||End Date||Price|
|Early Fee||15 Nov,2019||USD 1025.00|
|Regular Fee||05 Dec,2019||USD 1195.00|